gvtcx

supplier

Glenmark Pharmaceuticals Europe Limited

WD188YA combined from 3 published records

as a supplier

66 recorded awards from 10 buyers , between 10 May 2020 and 30 Apr 2026.

awards won
66
exclusive
0%
0 sole-winner awards
median award
£121.2m
largest
£469.7m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS National Generics Pharmaceuticals - Supply Chain Resilience shared NHS England £35,010,320 30 Apr 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
NHS National Framework for Transition Products (Nintedanib and Dalbavancin) shared NHS England £14,758,000 25 Feb 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin shared NHS England £25,881,000 25 Nov 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
National Procurement for HIV and Preventative Treatments shared NHSE&I £230,000,000 1 Feb 2022
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS National Generic Pharmaceuticals Interim 2 shared NHS England £12,327,097 21 Dec 2020
Contracts for the supply of Azithromycin & Dexamethasone products pt2 shared Department of Health and Social Care £2,108,686 10 May 2020
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 shared Regional Business Services Organisation, Procurement and Logistics Service · 3 Jul 2026
Generic, Branded Generic & Proprietary Medicinal Products - Group 18 shared Regional Business Services Organisation, Procurement and Logistics Service · 3 Jul 2026
NP36126 Antibiotic & Genito Urinary Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 25 May 2026
NP36126 Antibiotic & Genito Urinary Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 25 May 2026
HIV Medicines shared The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · 7 May 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NP49425 Generic and Biosimilar Transition Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 30 Mar 2026
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin shared NHS England · 30 Jan 2026
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · 6 Jan 2026
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · 6 Jan 2026

every contract won by Glenmark Pharmaceuticals Europe Limited →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Glenmark Pharmaceuticals Europe Limited · WD18 8YA 56
Glenmark Pharmaceuticals Europe Ltd GB-COH 05040260 WD18 8YA 6
Glenmark Pharmaceuticals Europe Limited GB-PPON PRVD-4666-TRCN HA3 0BU 4

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works